ACE |
Angiotensin converting enzyme |
AChEi |
Acetylcholinesterase inhibitors |
ACT |
Alpha-1 antichymotrypsin |
AD |
Alzheimer’s disease |
ADAS-Cog |
AD Assessment Scale-Cognitive Subscale |
ADDTC |
Alzheimer’s Disease Diagnostic and Treatment Centers |
APOE |
Apolipoprotein E |
ARIEN |
Association Internationale pour la Recherché et l’Enseignement en Neurosciences |
Aβ |
Amyloid beta |
BBB |
Blood-brain barrier |
BDNF |
Brain-derived neurotrophic factor |
CAST |
Chinese Acute Stroke Trial |
CCPL |
Choline-containing phospholipids |
CHANCE |
Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events |
CNS |
Central nervous system |
CRP |
C-reactive protein |
CSN |
Canadian Stroke Network |
CT |
Computed tomography |
DAMPs |
Danger associated molecular patterns |
DAPT |
Dual antiplatelet therapy |
DBP |
Diastolic blood pressure |
DEDEMAS |
Determinants of Dementia After Stroke |
DSM-5 |
Diagnostic and Statistical Manual of Mental Disorders Fifth Edition |
GCLM |
Glutamate-cysteine ligase modifier |
IL-6 |
Interleukin-6 |
IST |
International Stroke Trial |
MAO-i |
Monoamine oxidase inhibitor |
mCRP |
Monomeric C-reactive protein |
MMP-9 |
Matrixmetalloproteinase-9 |
MMSE |
Mini-Mental State Examination |
MoCA |
Montreal Cognitive Assessment |
MRI |
Magnetic resonance imaging |
mRS |
Modified Rankin Scale |
NIHSS |
National Institutes of Health stroke score |
NINDS |
National Institute of Neurological Disorders and Stroke |
NMDA |
N-methyl-d-aspartate |
NMDA-r |
N-methyl-d-aspartate receptor |
NOS3 |
Endothelial nitric oxide synthase |
POINT |
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke |
PRoFESS |
Prevention Regimen for Effectively Avoiding Second Strokes |
PROGRESS |
Perindopril Protection Against Recurrent Stroke Study |
PSD |
Post-stroke dementia |
RCT |
Randomized clinical trial |
SBP |
Systolic blood pressure |
SPARCL |
Stroke Prevention by Aggressive Reduction in Cholesterol Levels |
SPRINT-MIND |
Systolic Blood Pressure Intervention Trial Mind |
THALES |
Acute Stroke or Transient Ischemic Attack Treated With Ticagrelor and ASA for Pre-vention of Stroke and Death |
TIA |
Transient ischemic attack |
VaD |
Vascular dementia |
VASCOG |
International Society for Vascular Behavioral and Cognitive Disorders |
VCD |
vascular cognitive disorders |
VCI |
Vascular cognitive impairment |
VICCCS |
Vascular Impairment of Cognition Classification Consensus Study |